<p>Aspira Women’s Health Inc. 已與 Lincoln Park Capital Fund, LLC 簽署了一份購買協議，根據該協議，Lincoln Park 承諾在公司的指示下，分期購買最多 1000 萬美元的 Aspira 普通股。這些股票將作為未註冊證券在私募中發行和出售，依賴於《證券法》第 4(a)(2) 條和 D 規則 506(b) 的註冊豁免。與該協議相關，Aspira 還將向 SEC 提交註冊聲明，以覆蓋 Lincoln Park 對這些股票的轉售。Lincoln Park 是根據協議條款的合格投資者。免責聲明：本新聞簡報由公共技術公司（PUBT）使用生成性人工智能創建。雖然 PUBT 努力提供準確和及時的信息，但此 AI 生成的內容僅供參考，不應被解讀為財務、投資或法律建議。Aspira Women’s Health Inc. 於 2025 年 12 月 23 日通過美國證券交易委員會（Ref. ID: 0001104659-25-124245）運營的電子數據收集、分析和檢索系統 EDGAR 發佈了用於生成本新聞簡報的原始內容，並對此信息的準確性承擔全部責任。© 版權 2025 - 公共技術公司（PUBT）原始文檔：這裏</p>

<p>Aspira Women's Health Inc. 已與 Lincoln Park Capital Fund, LLC 簽署了一項 1000 萬美元的私募協議。Lincoln Park 將逐步購買最多 1000 萬美元的 Aspira 普通股。這些股票將作為未註冊證券發行，Aspira 將向 SEC 提交註冊聲明以進行轉售。根據協議，Lincoln Park 是一名合格投資者</p>

<p>Aspira Women’s Health Inc. has entered into a purchase agreement with Lincoln Park Capital Fund, LLC, under which Lincoln Park has committed to purchase up to $10 million of Aspira’s common stock at the company’s direction over time. The shares will be issued and sold in a private placement as unregistered securities, relying on exemptions from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D. In connection with the agreement, Aspira will also file a registration statement with the SEC to cover the resale of the shares by Lincoln Park. Lincoln Park is an accredited investor under the terms of the agreement. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspira Women’s Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-124245), on December 23, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>
<div class="lb-trans"><p>Aspira Women’s Health Inc. 已與 Lincoln Park Capital Fund, LLC 簽署了一份購買協議，根據該協議，Lincoln Park 承諾在公司的指示下，分期購買最多 1000 萬美元的 Aspira 普通股。這些股票將作為未註冊證券在私募中發行和出售，依賴於《證券法》第 4(a)(2) 條和 D 規則 506(b) 的註冊豁免。與該協議相關，Aspira 還將向 SEC 提交註冊聲明，以覆蓋 Lincoln Park 對這些股票的轉售。Lincoln Park 是根據協議條款的合格投資者。免責聲明：本新聞簡報由公共技術公司（PUBT）使用生成性人工智能創建。雖然 PUBT 努力提供準確和及時的信息，但此 AI 生成的內容僅供參考，不應被解讀為財務、投資或法律建議。Aspira Women’s Health Inc. 於 2025 年 12 月 23 日通過美國證券交易委員會（Ref. ID: 0001104659-25-124245）運營的電子數據收集、分析和檢索系統 EDGAR 發佈了用於生成本新聞簡報的原始內容，並對此信息的準確性承擔全部責任。© 版權 2025 - 公共技術公司（PUBT）原始文檔：這裏</p>
</div>

Aspira Women's Health 宣佈與 Lincoln Park Capital 達成 1000 萬美元的私募融資協議